Fibronectin-Assisted Coating of Low-Molecular-Weight Fucoidan Creates a Biomimetic Interface for Endothelialization of Cobalt-Chromium Stents
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Incomplete or delayed endothelialization after stent implantation compromises vascular healing and increases the risk of restenosis and late thrombosis. To address this limitation, Cobalt-Chromium (Co-Cr) stents were modified with a biomimetic coating combining Low-Molecular-Weight Fucoidan (LMWF), a sulfated polysaccharide with glycocalyx-mimetic properties, and fibronectin, to promote endothelial repair while preserving vascular homeostasis. The morphology, chemical composition, wettability and stability of the coating were characterized using complementary physicochemical approaches. The behavior of human endothelial cells cultured on this dual fibronectin-LMWF-coated stent was then assessed.
Our results showed that fibronectin-LMWF-based coating achieved a ten-fold higher surface density on the stent than LMWF alone (0.29 ± 0.04 vs 0.03 ± 0.01 µg/mm 2 ) and retained 0.27 ± 0.03 µg/mm 2 of the coating after 168 h, compared with 0.01 ± 0.01 µg/mm 2 for LMWF alone.
Although wettability remained similar to that of uncoated stents, the combined coating markedly enhanced endothelial cell adhesion, spreading, lamellipodia formation, proliferation, and MMP-2 secretion. These effects were accompanied by enhanced F-actin organization and redistribution of membrane-associated VE-cadherin, integrins β1 and α6, and syndecans-1 and-4, without major changes in their total expression. Importantly, the coating induced these responses without detectable cytotoxicity or significant inflammatory activation.
Overall, the fibronectin-LMWF-based coating provides a stable biomimetic interface that enhances endothelialization through coordinated remodeling of adhesion, cytoskeletal, and glycocalyx-associated structures, while maintaining endothelial homeostasis on Co-Cr stent. This strategy offers a promising platform for next-generation glycocalyx-like stent coatings designed to improve vascular healing and limit restenosis.
Fibronectin-assisted immobilization of low-molecular-weight fucoidan enhances endothelialization of Cobalt-Chromium stents. Schematic illustration of the sequential dip-coating modification of Cobalt-Chromium (Co-Cr) stents with fibronectin and low-molecular-weight fucoidan (LMWF), followed by HUVECs seeding and endothelial colonization. Fibronectin-assisted LMWF immobilization enhances coating retention and supports HUVECs adhesion, spreading, and proliferation. Representative microscopy images illustrate coating retention, endothelial morphology, surface colonization, and VE-cadherin distribution. The proposed coating architecture involves fibronectin adsorption onto the Co-Cr surface, followed by the formation of electrostatic interactions between fibronectin and LMWF as well as between LMWF and endothelial cell-surface components (selectins). Overall, these findings highlight the potential of fibronectin-LMWF coatings as a biomimetic strategy to promote Co-Cr stent endothelialization. Created in BioRender. Saadi, M. (2027) https://BioRender.com/6xb50t5 .